Totally selective synthesis of enantiopure (3S,5S)- and (3R,5R)-4-amino-3, 5-dihydroxypiperidines from aminodiepoxides derived from serine

Journal of Organic Chemistry

Volumn 73, Issue 15, 2008, Pages 6048-6051

  Concellón, José M ^a   Rivero, Ignacio A ^b   Rodríguez Solla, Humberto ^a   Concellón, Carmen ^a   España, Estibaly ^a   García Granda, Santiago ^b   Diaz M R ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b TIJUANA INSTITUTE OF TECHNOLOGY   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; AMINO ACIDS; CHEMICAL REACTIONS; DIFFERENCE EQUATIONS; MATHEMATICAL TRANSFORMATIONS; ORGANIC COMPOUNDS;

CHEMICAL EQUATIONS; ENANTIOPURE; SELECTIVE SYNTHESIS;

AMINATION;

3,5 DIHYDROXY 3 AMINOPIPERIDINE DERIVATIVE; 4 AMINO 3,5 DIHYDROXYPIPERIDINE DERIVATIVE; AMINE; AMINODIEPOXIDE; EPOXIDE; LITHIUM DERIVATIVE; N,N DIBENZYL 1,2:4,5 DIEPOXYPENTAN 3 AMINE; PIPERIDINE DERIVATIVE; SERINE;

ARTICLE; ENANTIOMER; MOLECULAR INTERACTION; NUCLEAR OVERHAUSER EFFECT; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTUM YIELD; REACTION ANALYSIS; RING OPENING; STEREOCHEMISTRY; SYNTHESIS; X RAY ANALYSIS;

AMINES; EPOXY COMPOUNDS; MOLECULAR STRUCTURE; PIPERIDINES; SERINE; STEREOISOMERISM;

EID: 48249109532     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo801058c     Document Type: Article

References (73)

1. (a) Cai, G.; Salonikidis Petrus, S.; Fei, J.; Schwarz, W.; Schüle-in, R.; Reutter, W.; Fan, H. FEBS J. 2005, 272, 1625-1638.
2. (b) Karaveg, K.; Siriwardena, A.; Tempel, W.; Liu, Z.-J.; Glushka, J.; Wang, B.-C.; Moremen, K. W. J. Biol. Chem. 2005, 280, 16197-16207.
3. (c) Zechel, D. L.; Withers, S. G. Acc. Chem. Res. 2000, 33, 11-18.
4. (d) Ganem, B. Acc. Chem. Res. 1996, 29, 340-347.
5. For a recent review, see: (a) Pearson, M. S. M.; Mathé-Allainmat, M.; Fargeas, V.; Lebreton, J. Eur. J. Org. Chem. 2005, 2159-2191.
6. (b) Asano, N. Glycobiology 2003, 13, 93R-104R.
7. (c) Asano, N. Curr. Top. Med. Chem. 2003, 3, 471-484.
8. (d) Compain, P.; Martin, O. R. Curr. Top. Med. Chem. 2003, 3, 541-560,
9. (e) Nash, R. J.; Watson, A. A.; Asano, N. In Alkaloids Chemical and Biological Perspectives; Pelletier, S. W., Ed.; Elsevier, Oxford, UK, 1996; Vol. 11, pp 345-376.
10. (f) Elbein, A. D.; Molyneux, R. J. In Comprehensive Natural Products; Barton, D., ; Nakanishi, K., Eds.; Elsevier: New York, 1999; Vol. 3, pp 129-160.
11. (a) Jespersen, T. M.; Dong, W.; Sierks, M. R.; Skrydstrup, T.; Lundt, I.; Bols, M. Angew. Chem., Int. Ed. Engl. 1994, 33, 1778-1779.
12. (b) Ichikawa, M.; Igarashi, Y.; Ichikawa, Y. Tetrahedron Lett. 1995, 36, 1767-1770.
13. (c) Ichikawa, Y.; Igarashi, Y. Tetrahedron Lett. 1995, 36, 4585-4586.
14. (d) Hansen, A.; Tagmose, T. M.; Bols, M. Chem. Commun. 1996, 2649, 2650.
15. (e) Nishimura, Y.; Satoh, T.; Kudo, T.; Kondo, S.; Takeuchi, T. Bioorg. Med. Chem. 1996, 4, 91-96.
16. (f) Igarashi, Y.; Ichikawa, M.; Ichikawa, Y. Tetrahedron Lett. 1996, 37, 2707-2708.
17. (g) Igarashi, Y.; Ichikawa, M.; Ichikawa, Y. Bioorg. Med. Chem. Lett. 1996, 6, 553-558.
18. (h) Bols, M.; Hazell, R. G.; Thomsen, I. B. Chem. - Eur. J. 1997, 3, 940-947.
19. (i) Ichikawa, Y.; Igarashi, Y.; Ichikawa, M.; Suhara, Y. J. Am. Chem. Soc. 1998, 120, 3007-3018.
20. (j) Nishimura, Y.: Shitara, E.; Adachi, H.; Toyoshima, M.; Nakajima, M.; Okami, Y.; Takeuchi, T. J. Org. Chem. 2000, 65, 2-11,
21. (k) Shitara, E.; Nishimura, Y.; Kojima, F.; Takeuchi, T. Bioorg. Med. Chem. 2000, 8, 343-352.
22. (l) Søhoel, H.; Liang, X.; Bols, M. J. Chem. Soc., Perkin Trans. 1 2001, 1584-1585.
23. (m) Jakobsen, P.; Lundbeck, J. M.; Kristiansen, M.; Breinholt, J.; Demuth, H.; Pawlas, J.; Candela, M. P. T.; Andersen, B.; Westergaard, N.; Lundgren, K.; Asano, N. Bioorg. Med. Chem. 2001, 9, 733-744.
24. (n) Liu, H.; Liang, X.; Søhoel, H. H.; Bülow, A., Bols, M. J. Am. Chem. Soc. 2001, 123, 5116-5117.
25. (a) Bols, M. Acc. Chem. Res. 1998, 31, 1-8.
26. (b) Iminosugars as Glycosidase Inhibitors. Nojirimicin and Beyond; Stütz, A. E., Ed.; Wiley-VCH: Weinheim, Germany, 1999.
27. (c) Somsak, L.; Nagy, V.; Hadady, Z.; Docsa, T.; Gergely, P. Curr. Pharm. Des. 2003, 9, 1177-1189.
28. (d) Greimel, P.; Spreitz, J.; Stutz, A. E.; Wrodnigg, T. M. Curr. Top. Med. Chem. 2003, 3, 513-523.
29. (e) Nishimura, Y. Curr. Top. Med. Chem. 2003, 3, 575-591.
30. (f) Butters, T. D.; Dwek, R. A.; Platt, F. M. Glycobiology 2005, 15, 43R.
31. For selected recent approaches, see: (a) Wang, R.-W.; Qing, F.-L. Org. Lett. 2005, 7, 2189-2192.
32. (b) Segraves, N. L.; Crews, P. J. Nat. Prod. 2005, 68, 118-121.
33. (c) Goodenough, K. M.; Raubo, P.; Harrity, J. P. A. Org. Lett. 2005, 7, 2993-2996.
34. (d) Martín, R.; Murruzzu, C.; Pericás, M. A.; Riera, A. J. Org. Chem. 2005, 70, 2325-2328.
35. (e) Lemire, A.; Charette, A. B. Org. Lett. 2005, 7, 2747.
36. (f) Legault, C. Y.; Charette, A. B. J. Am. Chem. Soc. 2005, 127, 8966-8967.
37. (g) Thomassigny, C.; Barroso, M. T.; Greck, C. Lett. Org. Chem. 2005, 2, 316-318.
38. (h) McDonnell, C.; Cronin, L.; O'Brien, J. L.; Murphy, P. V. J. Org. Chem. 2004, 69, 3565-3568.
39. (i) Takahata, H.; Banba, Y.; Sasatani, M.; Nemoto, H.; Kato, A.; Adachi, I. Tetrahedron 2004, 60, 8199-8205.
40. (j) Adelbrecht, J. C.; Craig, D.; Dymock, B. W.; Thorimbert, S. Synlett 2002, 467, 470.
41. (a) Kazmaier, U.; Schneider, C. Tetrahedron Lett. 1998, 39, 817-818.
42. (b) Kim, Y. J.; Ichikawa, M.; Ichikawa, Y. J. Org. Chem. 2000, 65, 2599-2602.
43. (c) Mehta, G.; Mohal, N. Tetrahedron Lett. 2000, 41, 5747-5751.
44. (d) Liang, X.; Lohse, A.; Bols, M. J. Org. Chem. 2000, 65, 7432-7437.
45. (e) Pandey, G.; Kapur, M. Tetrahedron Lett. 2000, 41, 8821-8824.
46. (f) Zhao, G.; Deo, U. C.; Ganem, B. Org. Lett. 2001, 3, 201-203.
47. (g) Pandey, G.; Kapur, M. Synthesis 2001, 1263, 1267.
48. (h) Andersch, J.; Bols, M. Chem. - Eur. J. 2001, 7, 3744-3747.
49. (i) Comins, D. L.; Fulp, A. B. Tetrahedron Lev. 2001, 42, 6839-6841.
50. (j) Best, W. M.; MacDonald, J. M.; Skelton, B. W.; Stick, R. V.; Tilbrook, D. M. G.; White, A. H. Can. J. Chem. 2002, 80, 857-865.
51. (k) Guanti, G.; Riva, R. Tetrahedron Lett. 2003, 44, 357-360.
52. (l) Pandey, G.; Kapur, M.; Khan, M. I.; Gaikwad, S. M. Org. Biomol. Chem. 2003, 1, 3321-3326.
53. (a) Whitesell, J. K. Chem. Rev. 1989, 89, 1581-1590.
54. (b) Konradi, A. W.; Pedersen, S. F. J. Org. Chem. 1992, 57, 28-32.
55. (c) Yu, Q.; Baroni, T. E.; Liable-Sands, L.; Rheingold, A. L.; Borovik, A. S. Tetrahedron Lett. 1998, 39, 6831-6834, and references cited therein,
56. (d) Stranne, R.; Vasse, J.-L.; Moberg, C. Org. Lett. 2001, 3, 2525-2528.
57. (a) Sugimura, T.; Inoue, S.; Tai, A. Tetrahedron Lett. 1998, 39, 6487-6490.
58. (b) Cserepi-Szucs, S.; Bakos, J. J. Chem. Soc. Chem. Commun. 1997, 635, 636.
59. (c) Schenk, W. A.; Stubbe, M.; Hagel, M. J. Organomet. Chem. 1998, 560, 257-263.
60. (d) Marinetti, A.; Kruger, V.; Buzin, F. X. Tetrahedron Lett. 1997, 38, 2947-2950.
61. (a) Menozzi, C.; Dalko, P. I.; Cossy, J. Chem. Commun. 2006, 4638-4640.
62. (b) Parker, K. A.; Katsoulid, I. A. Org. Lett. 2004, 6, 1413-1416.
63. (c) Morgan, B. P.; Swick, A. G.; Hargrove, D. M.; LaFlamme, J. A.; Moynihan, M. S.; Carroll, R. S.; Martin, K. A.; Lee, E.; Decosta, D.; Bordner, J. J. Chem. Med. 2002, 45, 2417-2424.
64. (d) Kempf, D. J.; Sham, H. L. Curr. Pharm. Des. 1996, 2, 225-246.
65. (e) Kempf, D. J.; Codacovi, L. M.; Wang, X. C.; Kohlbrenner, W. E.; Wideburg, N. E.; Saldivar, A.; Vasavanonda, S.; March, K. C.; Bryant, P.; Sham, H. L.; Green, B. E.; Betebenner, D. A.; Erickson, J. J.; Norbeck, D. W. J. Med. Chem. 1993, 36, 320-330.
66. (f) Erickson, J. J.; Neidhart, D. J.; Van Drie, J.; Kempf, D. J.; Wang, X. C.; Norbeck, D. W.; Pattner, J. J.; Rittenhouse, J. W.; Turon, M.; Wideburg, N. E.; Kohlbrenner, W. E.; Simmer, R.; Helfrich, R.; Paul, D. A.; Knigge, M. Science 1990, 249, 527-533.
67. Concellón, J. M.; Riego, E.; Rodríguez-Solla, H.; Plutín, A. M. J. Org. Chem. 2001, 66, 8661-8665.
68. The (3S,5S)-relative configuration of compound 3, employing as starting material (2R,4R)-N,N-dibenzyl-1,2:4, 5-diepoxypentan-3-amine 1, is explained because the priority of the substituents (by application of the Cahn-Ingold-Prelog priority rules) have changed during the course of the reaction.
69. Ariens, E. J. Med. Res. Rev. 1996, 6, 451-466.
70. Chini, M.; Crotti, P.; Macchia, F. Tetrahedron Lett. 1990, 31, 4661-4664.
71. (a) Concellón, J. M.; Suárez, J. R.; del Solar, V. J. Org. Chem. 2005, 70, 7447-7450.
72. (b) Concellón, J. M.; Cuervo, H.; Fernández-Fano, R. Tetrahedron 2001, 57, 8983-8987.
73. CCDC 687287 contains the supplementary crystallographic data for compound 3c. These data can be obtained free of charge via http://www.ccdc.cam. ac.uk/conts/retrieving.html (or the Cambridge Data Center 12 Union Road Cambridge CB2 1EZ UK fax (+44)1223-336-033 or deposit@ccdc.cam.ac.uk).